Letizia Ferella
Aosta, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study.
Journal: Tumori
Published: May 17, 2022
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 14, 2022
Outcomes and toxicities of re-irradiation for prostate cancer: A systematic review on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Journal: Cancer treatment reviews
Published: November 24, 2020
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 07, 2020
Recommendation for the contouring of limbic system in patients receiving radiation treatment: A pictorial review for the everyday practice and education.
Journal: Critical reviews in oncology/hematology
Published: June 23, 2020
Prognostic role of primary tumor, nodal neck, and retropharyngeal GTVs for unresectable sinonasal cancers treated with IMRT and chemotherapy.
Journal: Tumori
Published: August 28, 2019
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma.
Journal: Journal of cancer research and clinical oncology
Published: July 27, 2019
Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.
Journal: Head & neck
Published: April 11, 2019
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis.
Journal: Critical reviews in oncology/hematology
Published: February 28, 2019
Prevalence of Fatigue in Head and Neck Cancer Survivors.
Journal: The Annals of otology, rhinology, and laryngology
Published: February 01, 2019
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma.
Journal: Journal of cancer research and clinical oncology
Published: September 04, 2018
Moderate Hypofractionation in Patients with Low-risk Prostate Cancer: Long-term Outcomes.
Journal: Anticancer research
Published: December 06, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026